Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.

Indegene Digital Summit on Oct 17 & 18 to have pharma chiefs dwell on GenAI and commercialization strategy: Our Bureau, Bengaluru Monday, October 14, 2024, 09:00 Hrs [IST] Indegen ...

Mr Lowe said that while he was not opposed to vaccines, his life had been destroyed. The Public Health Agency (PHA) said the ...

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...

We recently compiled a list of the 10 Most Profitable NASDAQ Stocks To Invest In. In this article, we are going to take a ...

Letters to the editor on Trump, Sessler, impeachment, Newhouse, crossover voting, misleading veterans, picking a write-in and ...

A program to accelerate drug trials often provides the market with new drugs that are only marginally more effective, but ...

A summary of recent health news includes HIV transmission via organ transplants in Brazil, a reconsideration of Eli Lilly's ...

Flu season is emerging and, although the disease is not predicted to be as prominent as years past, doctors urge people to ...

This summary provides the latest updates in health news, including HIV cases from organ transplants in Brazil, Sanofi's ...

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

In the aftermath of the COVID pandemic, U.S. politicians aren’t just bad-mouthing vaccines — they’re pushing through laws that undermine them. If the trend continues, we risk losing the layer of ...